IPO Databook: DataMeds AI (MEDS US) - Oct 2026

108 Views09 Aug 2026 10:06

SUMMARY

DataMeds AI, Inc. is a holding company operating a micro health ecosystem through its portfolio of healthcare technology and pharmaceutical services companies, focusing on patient-centric solutions.
DataMeds AI, Inc. operates Wellgistics, LLC, a 50-state licensed pharmaceutical wholesaler serving over 5,000 pharmacies, and acquired Helomics Corporation in 2026.
The company reports a history of losses, anticipates continuing losses, and faces uncertainty regarding future financing.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Discussions

(Paid Plans Only)

Price Chart(Sign Up to Access)

Insight Stream